Schedule 13D ownership disclosure

Tango Therapeutics Inc

Common Stock · CUSIP: 87583X109

Event date: 2025-11-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Third Rock Ventures IV, L.P.Reported CIK 0001688327

    Shares: 9,374,574 · Class: 6.97%

  • Third Rock Ventures GP IV, L.P.Reported CIK 0001688326

    Shares: 9,374,574 · Class: 6.97%

  • TRV GP IV, LLCReported CIK 0001688325

    Shares: 9,374,574 · Class: 6.97%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-282980
Form type
SCHEDULE 13D/A
Filer
Tango Therapeutics, Inc.
CIK
CIK 1819133
Filed
Nov 14, 2025
Reporting period
Nov 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub